-
1
-
-
21444449880
-
Osteonecrosis of the jaw and bisphosphonates
-
Woo SB, Hande K, Richardson PG. Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 2005; 353: 99-102.
-
(2005)
N Engl J Med
, vol.353
, pp. 99-102
-
-
Woo, S.B.1
Hande, K.2
Richardson, P.G.3
-
2
-
-
33646836925
-
Narrative [corrected] review: Bisphosphonates and osteonecrosis of the jaws
-
Woo SB, Hellstein JW, Kalmar JR. Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 2006; 144: 753-61.
-
(2006)
Ann Intern Med
, vol.144
, pp. 753-761
-
-
Woo, S.B.1
Hellstein, J.W.2
Kalmar, J.R.3
-
3
-
-
0042861578
-
Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic
-
Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003; 61: 1115-7.
-
(2003)
J Oral Maxillofac Surg
, vol.61
, pp. 1115-1117
-
-
Marx, R.E.1
-
4
-
-
2142817155
-
Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases
-
Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004; 62: 527-34.
-
(2004)
J Oral Maxillofac Surg
, vol.62
, pp. 527-534
-
-
Ruggiero, S.L.1
Mehrotra, B.2
Rosenberg, T.J.3
Engroff, S.L.4
-
5
-
-
33847413194
-
Bisphosphonate-induced osteonecro sis of the jaw
-
Krueger CD, West PM, Sargent M, Lodolce AE, Pickard AS. Bisphosphonate-induced osteonecro sis of the jaw. Ann Pharmacother 2007; 41: 276-84.
-
(2007)
Ann Pharmacother
, vol.41
, pp. 276-284
-
-
Krueger, C.D.1
West, P.M.2
Sargent, M.3
Lodolce, A.E.4
Pickard, A.S.5
-
6
-
-
34250369331
-
Bisphosphonates and osteonecrosis of the jaw
-
Watts NB, Harris ST, McClung MR, Bilezikian JP, Greenspan SL, Luckey MM. Bisphosphonates and osteonecrosis of the jaw. Ann Intern Med 2006; 145: 791-2.
-
(2006)
Ann Intern Med
, vol.145
, pp. 791-792
-
-
Watts, N.B.1
Harris, S.T.2
McClung, M.R.3
Bilezikian, J.P.4
Greenspan, S.L.5
Luckey, M.M.6
-
7
-
-
33847284113
-
American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws
-
Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons
-
Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws J Oral Maxillofac Surg 2007; 65: 369-76.
-
(2007)
J Oral Maxillofac Surg
, vol.65
, pp. 369-376
-
-
-
8
-
-
32644468898
-
Osteonecrosis of the maxilla: An unusual complication of prolonged bisphosphonate therapy: a case report
-
Mehrotra B, Fantasia J, Nissel-Horowitz S, Vinarsky S, Ruggiero S. Osteonecrosis of the maxilla: an unusual complication of prolonged bisphosphonate therapy: a case report. Proc Am Soc Clin Oncol 2003; 22: 795.
-
(2003)
Proc Am Soc Clin Oncol
, vol.22
, pp. 795
-
-
Mehrotra, B.1
Fantasia, J.2
Nissel-Horowitz, S.3
Vinarsky, S.4
Ruggiero, S.5
-
9
-
-
0942295635
-
Osteonecrosis of the jaws associated with the use of bisphosphonates
-
Rosenberg TJ, Ruggiero S. Osteonecrosis of the jaws associated with the use of bisphosphonates. J Oral Maxillofac Surg 2003; 61(Suppl 1): 60.
-
(2003)
J Oral Maxillofac Surg
, vol.61
, Issue.SUPPL. 1
, pp. 60
-
-
Rosenberg, T.J.1
Ruggiero, S.2
-
10
-
-
0642316721
-
Bisphosphanates and oral cavity avascular bone necrosis
-
Migliorati CA. Bisphosphanates and oral cavity avascular bone necrosis. J Clin Oncol 2003; 21: 4253-4.
-
(2003)
J Clin Oncol
, vol.21
, pp. 4253-4254
-
-
Migliorati, C.A.1
-
11
-
-
0032468984
-
Bisphosphonates: Mechanisms of action
-
Fleisch H. Bisphosphonates: mechanisms of action. Endocr Rev 1998; 19: 80-100.
-
(1998)
Endocr Rev
, vol.19
, pp. 80-100
-
-
Fleisch, H.1
-
12
-
-
0032942599
-
Bisphosphonates: Pharmacology, mechanisms of action and clinical uses
-
Russell RG, Croucher PI, Rogers MJ. Bisphosphonates: pharmacology, mechanisms of action and clinical uses. Osteoporos Int 1999; 9(Suppl 2): S66-80.
-
(1999)
Osteoporos Int
, vol.9
, Issue.SUPPL. 2
-
-
Russell, R.G.1
Croucher, P.I.2
Rogers, M.J.3
-
13
-
-
0024406012
-
Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow
-
Hughes DE, MacDonald BR, Russell RG, Gowen M. Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow. J Clin Invest 1989; 83: 1930-5.
-
(1989)
J Clin Invest
, vol.83
, pp. 1930-1935
-
-
Hughes, D.E.1
MacDonald, B.R.2
Russell, R.G.3
Gowen, M.4
-
14
-
-
0029934545
-
Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption
-
Vitte C, Fleisch H, Guenther HL. Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption. Endocrinology 1996; 137: 2324-33.
-
(1996)
Endocrinology
, vol.137
, pp. 2324-2333
-
-
Vitte, C.1
Fleisch, H.2
Guenther, H.L.3
-
15
-
-
23844478623
-
The effects of suppressed bone remodeling by bisphosphonates on microdamage accumulation and degree of mineralization in the cortical bone of dog rib
-
Mashiba T, Mori S, Burr DB, Komatsubara S, Cao Y, Manabe T, et al. The effects of suppressed bone remodeling by bisphosphonates on microdamage accumulation and degree of mineralization in the cortical bone of dog rib. J Bone Miner Metab 2005; 23(Suppl): 36-42.
-
(2005)
J Bone Miner Metab
, vol.23
, Issue.SUPPL.
, pp. 36-42
-
-
Mashiba, T.1
Mori, S.2
Burr, D.B.3
Komatsubara, S.4
Cao, Y.5
Manabe, T.6
-
16
-
-
15944413442
-
Severely suppressed bone turnover: A potential complication of alendronate therapy
-
Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 2005; 90: 1294-301.
-
(2005)
J Clin Endocrinol Metab
, vol.90
, pp. 1294-1301
-
-
Odvina, C.V.1
Zerwekh, J.E.2
Rao, D.S.3
Maalouf, N.4
Gottschalk, F.A.5
Pak, C.Y.6
-
17
-
-
17644406724
-
Bisphosphonates and avascular necrosis of the jaw: A possible association
-
Carter G, Goss AN, Doecke C. Bisphosphonates and avascular necrosis of the jaw: a possible association. Med J Aust 2005; 182: 413-5.
-
(2005)
Med J Aust
, vol.182
, pp. 413-415
-
-
Carter, G.1
Goss, A.N.2
Doecke, C.3
-
18
-
-
33646015087
-
-
Expert panel recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaws. LDA J 2005; 64: 21-4.
-
Expert panel recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaws. LDA J 2005; 64: 21-4.
-
-
-
-
19
-
-
33748751877
-
Bisphosphonate-related osteonecrosis of the jaw: Background and guidelines for diagnosis, staging and management
-
Ruggiero SL, Fantasia J, Carlson E. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102: 433-41.
-
(2006)
Oral Surg Oral Med Oral Pathol Oral Radiol Endod
, vol.102
, pp. 433-441
-
-
Ruggiero, S.L.1
Fantasia, J.2
Carlson, E.3
-
20
-
-
33745082063
-
Practical guidelines for the prevention, diagnosis and treatment of osteonecrosis of the jaw in patients with cancer
-
Ruggiero SL, Gralow J, Marx RE, Hoff AO, Schubert MM, Huryn JM, et al. Practical guidelines for the prevention, diagnosis and treatment of osteonecrosis of the jaw in patients with cancer. J Clin Oncol Prac 2006; 2: 7-14.
-
(2006)
J Clin Oncol Prac
, vol.2
, pp. 7-14
-
-
Ruggiero, S.L.1
Gralow, J.2
Marx, R.E.3
Hoff, A.O.4
Schubert, M.M.5
Huryn, J.M.6
|